Core Viewpoint - Kangzhong Medical (688607.SH) reported a total operating revenue of 321 million yuan for the year 2025, representing a year-on-year growth of 7.52% [1] Financial Performance - The company recorded a net loss attributable to shareholders of the parent company amounting to 7.0998 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 15.6329 million yuan [1] - Basic loss per share was 0.08 yuan [1] Business Strategy - The company has been steadily advancing the application and transformation of new products and technologies, enriching its product line, enhancing market promotion, and improving product competitiveness [1] - There has been an increased effort in expanding new products, which has collectively driven steady growth in operating revenue [1]